Adenomatous Polyposis Coli
📧 Sign up to get email alerts when something new happens for Adenomatous Polyposis Coli.
Sign up freeTop drugs studied for this disease
-
EMA withdrawal · 2021-12-07EMA Application withdrawn: Flynpovi (eflornithine hydrochloride;sulindac) — Cancer Prevention Pharma (Ireland) Limited
EMA withdrew the application for Flynpovi (eflornithine hydrochloride; sulindac) for Adenomatous Polyposis Coli.
-
EMA withdrawal · 2011-04-06EMA Withdrawn: Onsenal (celecoxib) — Pfizer Limited
The EMA has withdrawn Onsenal (celecoxib) from consideration/market in 2011 under Pfizer Limited.